신질형성술 시장 규모, 점유율, 동향 분석 리포트 : 치료 유형별, 지역별, 부문별 예측(2024-2030년)

신질형성술 시장의 성장과 동향 :

Grand View Research의 최신 리포트에 따르면 세계의 신질형성술 시장 규모는 2030년까지 16억 7,000만 달러에 달할 전망입니다.

이 시장은 2024-2030년 연평균 복합 성장률(CAGR)5.04%로 성장할 것으로 예상됩니다. 시장의 주요 촉진요인은 이러한 수술을 지원하는 보험 및 정부 환급 정책, 트랜스젠더에 대한 사회적 수용성 확대입니다. 연구자들은 기존의 피부 이식을 대체할 수 있는 혁신적인 질 성형술 개발에 주력하고 있습니다. 이러한 기술 혁신을 통해 기존 수술 방법보다 더 효율적이고 저렴한 비용으로 수술을 할 수 있게 되었습니다.

일부 사람들은 자신의 신체적 특징을 자신의성 정체성과 일치시키기 위해 성전환 수술(SRS)을 선택합니다. 마운트 시나이 병원 트랜스젠더 의료 수술센터의 2021년 연례 보고서에 따르면 25-34세 트랜스젠더 인구의 약 41.7%, 15-24세 트랜스젠더 인구의 약 25.8%가 성전환 수술(SRS)을 받았다고 합니다. 마운트 시나이 병원에서는 약 861건의 SRS가 시행되었으며, 그 중 639건이 여성화를 목적으로 한 수술이었으며, 25세에서 34세 사이의 남성화된 사람들은 성전환 수술을 받는 경향이 높았으며, 전체 여성화 수술의 약 41%를 차지했습니다.

신질형성술 시장 보고서 하이라이트:

이 시장은 남성에서 여성으로의 수술 건수 증가와 보험 정책의 가용성으로 인해 크게 성장할 것으로 예상됩니다. 또한 의료진은 수술 시간을 단축하기 위해 혁신적인 새로운 질 성형술 기술을 개발하고 있습니다.

치료 유형별로는 남성에서 여성으로 성전환(MtF) 수술에 대한 수요가 증가함에 따라 성전환 수술 부문이 2023년 시장을 주도했습니다.

아시아태평양은 신질 성형술의 이용 가능성에 대한 인식이 높아지면서 2023년 시장을 장악했습니다. 일부 국가에서는 저렴한 비용으로 치료를 받을 수 있는 등의 요인으로 인해 외국인 환자 유입이 증가하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장 변수, 동향 및 범위

• 시장 계통 전망
  • 모시장 전망
• 시장 역학
  • 시장 촉진요인 분석
  • 시장 억제요인 분석
• 업계 분석 툴
  • Porter's Five Forces 분석
  • PESTLE 분석
• COVID-19 감염증의 영향 분석
• 신질형성술 : 공립 병원 vs. 사립 병원
• 상환 시나리오

제4장 신질형성술 시장 : 치료 유형의 분석

• 신질형성술 시장의 치료 유형의 변동 분석, 2023년 및 2030년
• 치료 유형별
  • 질형성 부전 치료 수술
  • 질폐쇄증치료 수술
  • 성전환수술

제5장 신질형성술 시장 : 지역 분석

• 신질형성술 지역 시장 점유율 분석, 2023년 및 2030년
• 지역 시장 스냅숏(시장 규모, CAGR)
• 북미
  • 북미 신질형성술 시장, 2018-2030년
  • 미국
  • 캐나다
• 유럽
  • 유럽 신질형성술 시장, 2018-2030년
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 스웨덴
  • 노르웨이
  • 덴마크
• 아시아태평양
  • 아시아태평양의 신질형성술 시장, 2018-2030년
  • 일본
  • 중국
  • 인도
  • 태국
  • 인도네시아
  • 한국
• 라틴아메리카
  • 라틴아메리카 신질형성술 시장, 2018-2030년
  • 브라질
  • 멕시코
  • 아르헨티나
• 중동 및 아프리카
  • 중동 및 아프리카의 신질형성술 시장, 2018-2030년
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제6장 경쟁 분석

• 기업 분류
• 기업의 시장 현황 분석
• 전략 매핑
  • 합병·인수
  • 협업
  • 신제품 발매
• 기업 개요
  • London Transgender Clinic
  • Phuket Plastic Surgery Institute(Bangkok Hospital Siriroj)
  • Icahn School of Medicine at Mount Sinai
  • Cedars-Sinai
  • Nationwide Children's Hospital
  • Ann &Robert H. Lurie Children's Hospital of Chicago(Lurie Children's)
  • CHETTAWUT PLASTIC SURGERY CENTER
  • Tips viz. Tricity Institute of Plastic Surgery
  • Gonzalez-Fontana

KSA 24.01.22

Neovaginal Surgery Market Growth & Trends:

The global neovaginal surgery market size is expected to reach USD 1.67 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 5.04% from 2024 to 2030. The primary drivers of the market are insurance and government reimbursement policies that offer support for these surgeries, and the increasing social acceptance of transgender individuals. Researchers are concentrating on creating innovative alternatives to traditional skin grafts for neovaginal construction. These innovations enable the procedure to be performed more efficiently and at a lower cost than conventional surgical methods.

Certain individuals choose Sex Reassignment Surgery (SRS) to bring their physical characteristics in line with their gender identity. As per the 2021 annual report from the Mount Sinai Center for Transgender Medicine and Surgery, approximately 41.7% of individuals within the transfeminine population between the ages of 25 and 34, and 25.8% within the age group of 15 to 24, have undergone Sex Reassignment Surgery (SRS). The Mount Sinai Hospital carried out approximately 861 SRS, with 639 specifically geared toward feminization. Individuals within the transmasculine population between the ages of 25 and 34 are more inclined to undergo gender-affirming surgeries, constituting approximately 41% of all the transfeminine surgeries performed.

Neovaginal Surgery Market Report Highlights:

• The market is projected to witness significant growth, owing to the high number of Male-to-Female surgeries and the availability of insurance policies. Moreover, medical practitioners are creating innovative neovaginal surgery techniques to reduce surgery time
• Based on the treatment type, the sex reassignment surgery segment dominated the market in 2023 owing to the increasing demand for Male-to-Female (MtF) procedures
• Asia Pacific dominated the market in 2023 due to the increasing awareness regarding the availability of neovaginal surgeries. Few destinations witnessed an increased influx of foreign patients due to factors such as the availability of treatments at low-cost

Table of Content

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation
  • 1.1.1. Treatment Type
  • 1.1.2. Region
• 1.2. Estimates and Forecast Timeline
• 1.3. Research Methodology
  • 1.3.1. Information procurement
  • 1.3.2. Purchased Database
  • 1.3.3. GVR's Internal Database
  • 1.3.4. Secondary Sources
  • 1.3.5. Primary Research
  • 1.3.6. Details of Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Validation
  • 1.5.1. Volume Price Analysis
• 1.6. List of Secondary Sources
• 1.7. List of Abbreviations
• 1.8. Research Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Industry Analysis Tools
  • 3.3.1. PORTER'S Five Forces Analysis
  • 3.3.2. PESTLE Analysis
• 3.4. COVID-19 Impact Analysis
• 3.5. Neovaginal Surgery: Public Hospitals vs. Private Hospitals
• 3.6. Reimbursement Scenario

Chapter 4. Neovaginal Surgery Market: Treatment Type Analysis

• 4.1. Neovaginal Surgery Market Treatment Type Movement Analysis, 2023 & 2030
• 4.2. Neovaginal Surgery Market Estimates & Forecasts, By Treatment Type (USD Million)
  • 4.2.1. Vaginal Agenesis Treatment Surgery
    • 4.2.1.1. Vaginal agenesis treatment surgery market, 2018 - 2030 (USD Million)
  • 4.2.2. Vaginal Atresia Treatment Surgery
    • 4.2.2.1. Vaginal atresia treatment surgery market, 2018 - 2030 (USD Million)
    • 4.2.2.2. McIndoe technique
    • 4.2.2.2.1. McIndoe technique market, 2018 - 2030 (USD Million)
    • 4.2.2.3. Vecchietti Technique
    • 4.2.2.3.1. Vecchietti technique market, 2018 - 2030 (USD Million)
  • 4.2.3. Sex Reassignment Surgery
    • 4.2.3.1.1. Sex reassignment surgery market, 2018 - 2030 (USD Million)

Chapter 5. Neovaginal Surgery Market: Regional Analysis

• 5.1. Neovaginal Surgery Regional Market Share Analysis, 2023 & 2030
• 5.2. Regional Market Snapshot (Market Size, CAGR)
• 5.3. North America
  • 5.3.1. North America Neovaginal Surgery Market, 2018 - 2030 (USD Million)
  • 5.3.2. U.S.
    • 5.3.2.1. Key country dynamics
    • 5.3.2.2. Regulatory framework
    • 5.3.2.3. Competitive scenario
    • 5.3.2.4. U.S. neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.3.3. Canada
    • 5.3.3.1. Key country dynamics
    • 5.3.3.2. Regulatory framework
    • 5.3.3.3. Competitive scenario
    • 5.3.3.4. Canada neovaginal surgery market, 2018 - 2030 (USD Million)
• 5.4. Europe
  • 5.4.1. Europe Neovaginal Surgery Market, 2018 - 2030 (USD Million)
  • 5.4.2. Germany
    • 5.4.2.1. Key country dynamics
    • 5.4.2.2. Regulatory framework
    • 5.4.2.3. Competitive scenario
    • 5.4.2.4. Germany neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.4.3. UK
    • 5.4.3.1. Key country dynamics
    • 5.4.3.2. Regulatory framework
    • 5.4.3.3. Competitive scenario
    • 5.4.3.4. UK neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.4.4. France
    • 5.4.4.1. Key country dynamics
    • 5.4.4.2. Regulatory framework
    • 5.4.4.3. Competitive scenario
    • 5.4.4.4. France neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.4.5. Italy
    • 5.4.5.1. Key country dynamics
    • 5.4.5.2. Regulatory framework
    • 5.4.5.3. Competitive scenario
    • 5.4.5.4. Italy neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.4.6. Spain
    • 5.4.6.1. Key country dynamics
    • 5.4.6.2. Regulatory framework
    • 5.4.6.3. Competitive scenario
    • 5.4.6.4. Spain neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.4.7. Sweden
    • 5.4.7.1. Key country dynamics
    • 5.4.7.2. Regulatory framework
    • 5.4.7.3. Competitive scenario
    • 5.4.7.4. Sweden neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.4.8. Norway
    • 5.4.8.1. Key country dynamics
    • 5.4.8.2. Regulatory framework
    • 5.4.8.3. Competitive scenario
    • 5.4.8.4. Norway neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.4.9. Denmark
    • 5.4.9.1. Key country dynamics
    • 5.4.9.2. Regulatory framework
    • 5.4.9.3. Competitive scenario
    • 5.4.9.4. Denmark neovaginal surgery market, 2018 - 2030 (USD Million)
• 5.5. Asia Pacific
  • 5.5.1. Asia Pacific Neovaginal Surgery Market, 2018 - 2030 (USD Million)
  • 5.5.2. Japan
    • 5.5.2.1. Key country dynamics
    • 5.5.2.2. Regulatory framework
    • 5.5.2.3. Competitive scenario
    • 5.5.2.4. Japan neovaginal surgery market, 2018 - 2030 (USD Million).
  • 5.5.3. China
    • 5.5.3.1. Key country dynamics
    • 5.5.3.2. Regulatory framework
    • 5.5.3.3. Competitive scenario
    • 5.5.3.4. China neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.5.4. India
    • 5.5.4.1. Key country dynamics
    • 5.5.4.2. Regulatory framework
    • 5.5.4.3. Competitive scenario
    • 5.5.4.4. India neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.5.5. Thailand
    • 5.5.5.1. Key country dynamics
    • 5.5.5.2. Regulatory framework
    • 5.5.5.3. Competitive scenario
    • 5.5.5.4. Thailand neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.5.6. Indonesia
    • 5.5.6.1. Key country dynamics
    • 5.5.6.2. Regulatory framework
    • 5.5.6.3. Competitive scenario
    • 5.5.6.4. Indonesia neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.5.7. South Korea
    • 5.5.7.1. Key country dynamics
    • 5.5.7.2. Regulatory framework
    • 5.5.7.3. Competitive scenario
    • 5.5.7.4. South Korea neovaginal surgery market, 2018 - 2030 (USD Million)
• 5.6. Latin America
  • 5.6.1. Latin America Neovaginal Surgery Market, 2018 - 2030 (USD Million)
  • 5.6.2. Brazil
    • 5.6.2.1. Key country dynamics
    • 5.6.2.2. Regulatory framework
    • 5.6.2.3. Competitive scenario
    • 5.6.2.4. Brazil neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.6.3. Mexico
    • 5.6.3.1. Key country dynamics
    • 5.6.3.2. Regulatory framework
    • 5.6.3.3. Competitive scenario
    • 5.6.3.4. Mexico neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.6.4. Argentina
    • 5.6.4.1. Key country dynamics
    • 5.6.4.2. Regulatory framework
    • 5.6.4.3. Competitive scenario
    • 5.6.4.4. Argentina neovaginal surgery market, 2018 - 2030 (USD Million)
• 5.7. Middle East & Africa
  • 5.7.1. Middle East & Africa Neovaginal Surgery Market, 2018 - 2030 (USD Million)
  • 5.7.2. South Africa
    • 5.7.2.1. Key country dynamics
    • 5.7.2.2. Regulatory framework
    • 5.7.2.3. Competitive scenario
    • 5.7.2.4. South Africa neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.7.3. Saudi Arabia
    • 5.7.3.1. Key country dynamics
    • 5.7.3.2. Regulatory framework
    • 5.7.3.3. Competitive scenario
    • 5.7.3.4. Saudi Arabia neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.7.4. UAE
    • 5.7.4.1. Key country dynamics
    • 5.7.4.2. Regulatory framework
    • 5.7.4.3. Competitive scenario
    • 5.7.4.4. UAE neovaginal surgery market, 2018 - 2030 (USD Million)
  • 5.7.5. Kuwait
    • 5.7.5.1. Key country dynamics
    • 5.7.5.2. Regulatory framework
    • 5.7.5.3. Competitive scenario
    • 5.7.5.4. Kuwait neovaginal surgery market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Analysis

• 6.1. Company Categorization
• 6.2. Company Market Position Analysis
• 6.3. Strategy Mapping
  • 6.3.1. Merger& Acquisition
  • 6.3.2. Collaborations
  • 6.3.3. New Product Launch
• 6.4. Company Profiles
  • 6.4.1. London Transgender Clinic
    • 6.4.1.1. Company overview
    • 6.4.1.2. Financial performance
    • 6.4.1.3. Product benchmarking
    • 6.4.1.4. Strategic initiatives
  • 6.4.2. Phuket Plastic Surgery Institute (Bangkok Hospital Siriroj)
    • 6.4.2.1. Company overview
    • 6.4.2.2. Financial performance
    • 6.4.2.3. Product benchmarking
    • 6.4.2.4. Strategic initiatives
  • 6.4.3. Icahn School of Medicine at Mount Sinai
    • 6.4.3.1. Company overview
    • 6.4.3.2. Financial performance
    • 6.4.3.3. Product benchmarking
    • 6.4.3.4. Strategic initiatives
  • 6.4.4. Cedars-Sinai
    • 6.4.4.1. Company overview
    • 6.4.4.2. Financial performance
    • 6.4.4.3. Product benchmarking
    • 6.4.4.4. Strategic initiatives
  • 6.4.5. Nationwide Children's Hospital
    • 6.4.5.1. Company overview
    • 6.4.5.2. Financial performance
    • 6.4.5.3. Product benchmarking
    • 6.4.5.4. Strategic initiatives
  • 6.4.6. Ann & Robert H. Lurie Children's Hospital of Chicago (Lurie Children's)
    • 6.4.6.1. Company overview
    • 6.4.6.2. Financial performance
    • 6.4.6.3. Product benchmarking
    • 6.4.6.4. Strategic initiatives
  • 6.4.7. CHETTAWUT PLASTIC SURGERY CENTER
    • 6.4.7.1. Company overview
    • 6.4.7.2. Financial performance
    • 6.4.7.3. Product benchmarking
    • 6.4.7.4. Strategic initiatives
  • 6.4.8. Tips viz. Tricity Institute of Plastic Surgery
    • 6.4.8.1. Company overview
    • 6.4.8.2. Financial performance
    • 6.4.8.3. Product benchmarking
    • 6.4.8.4. Strategic initiatives
  • 6.4.9. Gonzalez-Fontana
    • 6.4.9.1. Company overview
    • 6.4.9.2. Financial performance
    • 6.4.9.3. Product benchmarking
    • 6.4.9.4. Strategic initiatives